IDEAS home Printed from https://ideas.repec.org/a/sae/sagope/v7y2017i2p2158244017709323.html
   My bibliography  Save this article

Disability Levels and Cognitive Functioning Reported by Patients Impaired by Gentamicin and Other Aminoglycosides

Author

Listed:
  • Ann M. Kerlin

Abstract

The purpose of this study was to explore disability levels and cognitive functioning in patients who reported being damaged by aminoglycosides, a class of antibiotic drugs. An online questionnaire was published using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) and the NeuroQol Cognitive Functioning v.2. Gentamicin was the most frequent cause of impairment in patients, and the overall disability level was moderate (46.05%). Severe impairments were reported in mobility (Getting Around: 53.67%), Life Activities (60.20%), and Participation in Society (55.19%), and the NeuroQol Cognitive Function measure was approximately 1 standard deviation below normal. Participants who reported impairment from gentamicin and other aminoglycosides indicate a diminished quality of life, along with accompanying depression and anxiety.

Suggested Citation

  • Ann M. Kerlin, 2017. "Disability Levels and Cognitive Functioning Reported by Patients Impaired by Gentamicin and Other Aminoglycosides," SAGE Open, , vol. 7(2), pages 21582440177, May.
    • Handle: RePEc:sae:sagope:v:7:y:2017:i:2:p:2158244017709323
    DOI: 10.1177/2158244017709323
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/2158244017709323
    Download Restriction: no
    File URL: https://libkey.io/10.1177/2158244017709323?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:sagope:v:7:y:2017:i:2:p:2158244017709323. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.